𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive-behavioral therapy for depression in Parkinson's disease: A pilot study

✍ Scribed by Roseanne DeFronzo Dobkin; Lesley A. Allen; Matthew Menza


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
72 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The present study was conducted to examine the feasibility and effect of an individual cognitive‐behavioral treatment (CBT) for depression that was modified to meet the unique needs of the PD patient and incorporated a separate social support intervention for caregivers. Fifteen PD patients with Major Depressive Disorder participated in the study with a caregiver. Patients received 10–14 sessions of modified individual CBT. Caregivers attended 3–4 psychoeducational sessions, occurring separately from the patients treatment sessions, which focused on strategies for offering appropriate support, and ways to respond to the patients' negative thoughts in a targeted manner. Patients experienced a significant reduction in depressive symptoms and negative cognitions, and an increased perception of social support over the course of treatment. Gains were maintained at 1‐month follow‐up. In conclusion, individual CBT, when modified appropriately, may be a feasible and effective option for PD depression. Larger, randomized controlled trials are needed to further evaluate the efficacy of this intervention and to identify specific mechanisms of change. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Bright light therapy in Parkinson's dise
✍ Sebastian Paus; Tanja Schmitz-Hübsch; Ullrich Wüllner; Antje Vogel; Thomas Klock 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

## Abstract Several observations suggest a beneficial effect of melatonin antagonism for Parkinson's disease (PD). Although bright light therapy (BLT) suppresses melatonin release and is an established treatment for depression and sleep disturbances, it has not been evaluated in PD. We examined eff

Ethosuximide and tremor in Parkinson's d
✍ E. Pourcher; B. Gomez-Mancilla; Dr. P. J. Bédard 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 1 views

## Abstract Following the demonstration of an antitremor effect of ethosuximide in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) monkey model, we have tested the effect of this drug in 10 patients with typical parkinsonian tremor. Six patients suffered from Parkinson's disease with promin

Humour therapy in patients with late-lif
✍ Marc Walter; Beat Hänni; Myriam Haug; Isabelle Amrhein; Eva Krebs-Roubicek; Fran 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Background Of the disabling disorders of the elderly, depression is the most common affective disorder and Alzheimer's disease (AD) the most common neurodegenerative disorder. Pharmacological treatment strategies for these disorders are often accompanied with severe side effects. Th

Brief cognitive–behavioral intervention
✍ Rebecca S. Bernard; Sharon E. Williams; Amy Storfer-Isser; William Rhine; Sarah 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 84 KB

## Abstract Parents of hospitalized premature infants are at risk for developing psychological symptoms. This randomized controlled pilot study examined the effectiveness of a brief cognitive–behavioral intervention in reducing traumatic and depressive symptoms in mothers 1 month after their infant

Excess burden of constipation in Parkins
✍ Julie Kaye; Heather Gage; Alan Kimber; Lesley Storey; Patrick Trend 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

An analysis was undertaken of clinic-based questionnaires that asked people with Parkinson's disease and a control group of older people without a known neurological condition about their experiences of constipation. People with Parkinson's disease report higher constipation on a validated objective